REPAGLINIDE
Substance profile for UNII 668Z8C33LU, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 65981Substance Identity#
- UNII
- 668Z8C33LU
- Preferred term
- REPAGLINIDE
- Registry number
- 135062-02-1
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C27H36N2O4
Structure render from PubChem CID 65981Chemical And Database Identifiers#
- InChIKey
- FAEKWTJYAYMJKF-QHCPKHFHSA-N
- SMILES
- CCOC1=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)=CC=C1C(O)=O
- RxCUI
- 73044
- PubChem
- 65981
- NCIt
- C47703
- INN ID
- 6818
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| REPAGLINIDE | ACTIVE INGREDIENT | 668Z8C33LU | PRANDIN ® (repaglinide) Tablets (0.5, 1, and 2 mg) | 3 | |
| REPAGLINIDE | ACTIVE MOIETY | 668Z8C33LU | PRANDIN ® (repaglinide) Tablets (0.5, 1, and 2 mg) | 3 | |
| REPAGLINIDE | ACTIVE MOIETY | 668Z8C33LU | PRANDIN (REPAGLINIDE) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 429 | |
| REPAGLINIDE | ACTIVE INGREDIENT | 668Z8C33LU | PRANDIN (REPAGLINIDE) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 429 | |
| REPAGLINIDE | ACTIVE INGREDIENT | 668Z8C33LU | PRANDIN (REPAGLINIDE) TABLET [NOVO NORDISK] | 8 | |
| REPAGLINIDE | ACTIVE MOIETY | 668Z8C33LU | PRANDIN (REPAGLINIDE) TABLET [NOVO NORDISK] | 8 | |
| REPAGLINIDE | ACTIVE MOIETY | 668Z8C33LU | PRANDIMET (REPAGLINIDE AND METFORMIN HYDROCHLORIDE) TABLET [NOVO NORDISK] | 7 | |
| REPAGLINIDE | ACTIVE INGREDIENT | 668Z8C33LU | PRANDIMET (REPAGLINIDE AND METFORMIN HYDROCHLORIDE) TABLET [NOVO NORDISK] | 7 | |
| REPAGLINIDE | ACTIVE MOIETY | 668Z8C33LU | REPAGLINIDE TABLET [MYLAN PHARMACEUTICALS INC.] | 6 | |
| REPAGLINIDE | ACTIVE INGREDIENT | 668Z8C33LU | REPAGLINIDE TABLET [MYLAN PHARMACEUTICALS INC.] | 6 | |
| REPAGLINIDE | ACTIVE INGREDIENT | 668Z8C33LU | REPAGLINIDE TABLET [PADDOCK LABORATORIES, LLC] | 5 | |
| REPAGLINIDE | ACTIVE MOIETY | 668Z8C33LU | REPAGLINIDE TABLET [PADDOCK LABORATORIES, LLC] | 5 | |
| REPAGLINIDE | ACTIVE MOIETY | 668Z8C33LU | PRANDIN (REPAGLINIDE) TABLET [CARDINAL HEALTH] | 4 | |
| REPAGLINIDE | ACTIVE INGREDIENT | 668Z8C33LU | PRANDIN (REPAGLINIDE) TABLET [CARDINAL HEALTH] | 4 | |
| REPAGLINIDE | ACTIVE MOIETY | 668Z8C33LU | REPAGLINIDE TABLET [MYLAN INSTITUTIONAL INC.] | 4 | |
| REPAGLINIDE | ACTIVE INGREDIENT | 668Z8C33LU | REPAGLINIDE TABLET [MYLAN INSTITUTIONAL INC.] | 4 | |
| REPAGLINIDE | ACTIVE INGREDIENT | 668Z8C33LU | REPAGLINIDE TABLET [SANDOZ INC] | 3 | |
| REPAGLINIDE | ACTIVE MOIETY | 668Z8C33LU | REPAGLINIDE TABLET [SANDOZ INC] | 3 | |
| REPAGLINIDE | ACTIVE MOIETY | 668Z8C33LU | REPAGLINIDE TABLET [SUN PHARMACEUTICAL INDUSTRIES, INC.] | 3 | |
| REPAGLINIDE | ACTIVE INGREDIENT | 668Z8C33LU | REPAGLINIDE TABLET [SUN PHARMACEUTICAL INDUSTRIES, INC.] | 3 | |
| REPAGLINIDE | ACTIVE MOIETY | 668Z8C33LU | PRANDIN (REPAGLINIDE) TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| REPAGLINIDE | ACTIVE INGREDIENT | 668Z8C33LU | PRANDIN (REPAGLINIDE) TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| REPAGLINIDE | ACTIVE INGREDIENT | 668Z8C33LU | PRANDIN (REPAGLINIDE) TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| REPAGLINIDE | ACTIVE MOIETY | 668Z8C33LU | PRANDIN (REPAGLINIDE) TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| REPAGLINIDE | ACTIVE MOIETY | 668Z8C33LU | REPAGLINIDE TABLET [AUROBINDO PHARMA LIMITED] | 2 | |
| REPAGLINIDE | ACTIVE INGREDIENT | 668Z8C33LU | REPAGLINIDE TABLET [AUROBINDO PHARMA LIMITED] | 2 | |
| REPAGLINIDE | ACTIVE INGREDIENT | 668Z8C33LU | REPAGLINIDE TABLET [BRECKENRIDGE PHARMACEUTICAL, INC.] | 2 | |
| REPAGLINIDE | ACTIVE MOIETY | 668Z8C33LU | REPAGLINIDE TABLET [BRECKENRIDGE PHARMACEUTICAL, INC.] | 2 | |
| REPAGLINIDE | ACTIVE MOIETY | 668Z8C33LU | PRANDIN (REPAGLINIDE) TABLET [REMEDYREPACK INC. ] | 1 | |
| REPAGLINIDE | ACTIVE INGREDIENT | 668Z8C33LU | PRANDIN (REPAGLINIDE) TABLET [REMEDYREPACK INC. ] | 1 | |
| REPAGLINIDE | ACTIVE INGREDIENT | 668Z8C33LU | REPAGLINIDE (REPAGLINIDE) TABLET [AVKARE, INC.] | 1 | |
| REPAGLINIDE | ACTIVE MOIETY | 668Z8C33LU | REPAGLINIDE (REPAGLINIDE) TABLET [AVKARE, INC.] | 1 | |
| REPAGLINIDE | ACTIVE MOIETY | 668Z8C33LU | REPAGLINIDE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| REPAGLINIDE | ACTIVE INGREDIENT | 668Z8C33LU | REPAGLINIDE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| REPAGLINIDE | ACTIVE INGREDIENT | 668Z8C33LU | REPAGLINIDE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| REPAGLINIDE | ACTIVE MOIETY | 668Z8C33LU | REPAGLINIDE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| REPAGLINIDE | ACTIVE INGREDIENT | 668Z8C33LU | REPAGLINIDE TABLET [CITRON PHARMA LLC] | 1 | |
| REPAGLINIDE | ACTIVE MOIETY | 668Z8C33LU | REPAGLINIDE TABLET [CITRON PHARMA LLC] | 1 | |